Your SlideShare is downloading. ×
  • Like
C1 - Transparency - Shum - Salon B
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

C1 - Transparency - Shum - Salon B

  • 39 views
Published

 

Published in Technology , Economy & Finance
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
39
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Transparency in the Evaluation & Funding ProcessHow far can we go?David Shum, PharmD, MBADirector, Reimbursement & Health EconomicsRoche Pharmaceuticals2013 CADTH SymposiumSt. John’s, NLMay 6, 2013
  • 2. Increasing focus on transparency issuesRef: Google ngram viewer1900 1950 2000
  • 3. ‘‘committed to transparency’’- US delegation (NYT, March 2013)
  • 4. ‚supersecretive in one part about our products…but there are otherareas where we will be completely transparent‛Source: BusinessWeek, Dec 2012
  • 5. Source: FT, April 2013
  • 6. Transparency Index across HTA countriesRef: Roche data
  • 7. Fair & open processPrinciples: priority settingPatient / stakeholdersCCIPatient dataResources
  • 8. GovernmentInformation should be exempt from the generalrule of public accessDisclosure of information would prejudice theireconomic interest‚any prejudice to the Ministry’s economic interestin this regard has a repercussive, concomitantnegative impact on the government’s financialinterest…‛
  • 9. IndustryInformation should be exempt from the generalrule of public accessCommercial information - confidential businesstactics, strategies, and plans
  • 10. • Positive steps to increasingtransparency in trial data andHTA• Tradeoffs between totaltransparency and opacityTowards increasing transparency
  • 11. We Innovate Healthcare